Skip to content
Breaking News

Breaking News

  • Home
  • World
  • Business
  • Health
  • Entertainment
  • Life Style
  • Sports
  • Toggle search form

Tag: Breaking News: Business

Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

Posted on May 12, 2025 By Admin No Comments on Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 
Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S….

Read More “Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know ” »

Health

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

Posted on April 4, 2025 By Admin No Comments on Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk.  Reuters President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. But the Centers…

Read More “Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound” »

Health

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

Posted on November 26, 2024 By Admin No Comments on Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Tuesday said its experimental weight loss injection helped patients with obesity lose up to 20% of their weight on average after a year in a critical mid-stage trial, as the company races…

Read More “Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau” »

Health

What McDonald’s needs to do next after E. coli outbreak

Posted on October 25, 2024 By Admin No Comments on What McDonald’s needs to do next after E. coli outbreak
What McDonald’s needs to do next after E. coli outbreak

In this photo illustration, a McDonald’s Quarter Pounder hamburger meal is seen at a McDonald’s on October 23, 2024 in the Flatbush neighborhood in the Brooklyn borough of New York City.  Michael M. Santiago | Getty Images As McDonald’s and health authorities race to contain a deadly E. coli outbreak, the burger chain faces challenges…

Read More “What McDonald’s needs to do next after E. coli outbreak” »

Health

FTC sues drug middlemen for allegedly inflating insulin prices

Posted on September 21, 2024 By Admin No Comments on FTC sues drug middlemen for allegedly inflating insulin prices
FTC sues drug middlemen for allegedly inflating insulin prices

Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office Building on May 15, 2024 in Washington, DC.  Kevin Dietsch | Getty Images News | Getty Images The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the…

Read More “FTC sues drug middlemen for allegedly inflating insulin prices” »

Health

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Posted on August 20, 2024 By Admin No Comments on Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial
Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo, according to initial results from a long-term study released Tuesday.  The late-stage trial on tirzepatide, the active ingredient in the company’s weight loss injection Zepbound and diabetes…

Read More “Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial” »

Health

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

Posted on August 2, 2024 By Admin No Comments on Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the U.S. Food and Drug…

Read More “Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says” »

Health

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

Posted on February 15, 2024 By Admin No Comments on In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks
In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month price targets every few weeks. To that end, we’re…

Read More “In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks” »

Health

FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

Posted on September 1, 2023 By Admin No Comments on FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition
FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition

The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images The Federal Trade Commission on Friday said it has reached a deal with drug giant Amgen to allow the company’s $27.8 billion purchase of Horizon Therapeutics to move forward.  The two companies now expect…

Read More “FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition” »

Health

Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know

Posted on July 8, 2023 By Admin No Comments on Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know
Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know

The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer’s treatment Leqembi, a major turning point for patients who are diagnosed with the early stages of the disease. Leqembi is the only drug on the…

Read More “Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know” »

Health

Recent Posts

  • Woman declared dead by coroner, moved to coffin, turns out to be alive
  • Shohei Ohtani reacts to death of Japanese baseball legend Shigeo Nagashima: ‘May your soul rest in peace’
  • Thames Water nationalisation ‘not the answer’ says minister after rescue bid fails
  • “Family Guy” creator Seth MacFarlane on his other love: Sinatra
  • Gilgit-Baltistan reports first case of poliovirus in toddler

Categories

  • Business
  • Entertainment
  • Health
  • Life Style
  • Sports
  • World

Copyright © 2025 Breaking News.

Powered by PressBook Blog WordPress theme